Over the past few years, aptamers have emerged as a new class of targeting ligands for diagnostic and therapeutic applications in cancer therapy, owing to their ability to bind to targets with high affinity and specificity. As a leading provider in complement therapeutics, Creative Biolabs gathered a team of scientific minds specializing in aptamer development… Read more »